Evidence-based toxicology: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 38: | Line 38: | ||
[[Category:Evidence-based practices]] | [[Category:Evidence-based practices]] | ||
[[Category:Medical research]] | [[Category:Medical research]] | ||
{{No image}} | |||
Revision as of 16:56, 10 February 2025
Evidence-based toxicology (EBT) is a discipline that applies the principles and methods of evidence-based medicine to the field of toxicology. It aims to transparently, consistently, and objectively assess available scientific evidence in order to answer questions in toxicology.
History
The concept of EBT was first proposed in 2006 by a group of toxicologists and systematic review experts. The idea was to apply the principles of evidence-based medicine to toxicology, in order to improve the transparency, consistency, and objectivity of assessments in the field.
Principles
EBT is based on the following principles:
- Transparency in the process of assessment
- Consistency in the application of criteria
- Objectivity in the interpretation of evidence
These principles are applied through the use of systematic review methods, which involve a structured and documented process for identifying, selecting, and appraising relevant studies.
Applications
EBT can be applied in various areas of toxicology, including:
- Risk assessment
- Regulatory toxicology
- Forensic toxicology
- Clinical toxicology
- Environmental toxicology
Challenges
Despite its potential benefits, the implementation of EBT faces several challenges. These include the need for training in systematic review methods, the need for more high-quality studies in toxicology, and the need for tools and resources to facilitate the application of EBT.
Future Directions
The future of EBT lies in the continued development and refinement of systematic review methods for toxicology, as well as in the integration of these methods into regulatory decision-making processes.


